Pharming Group NV
NASDAQ:PHAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
NASDAQ:PHAR
|
NL |
|
Trilogy Metals Inc
TSX:TMQ
|
CA |
|
S4 Capital PLC
LSE:SFOR
|
UK |
|
Madhav Copper Ltd
NSE:MCL
|
IN |
|
C
|
Compania Cervecerias Unidas SA
SGO:CCU
|
CL |
|
PMV Pharmaceuticals Inc
NASDAQ:PMVP
|
US |
|
Iluka Resources Ltd
ASX:ILU
|
AU |
|
C
|
Coupa Software Inc
F:2C0
|
US |
Shareholder Yield
Current shareholder yield for 
PHAR is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PHAR Price
Pharming Group NV
| Average Annual Return | -1.8% |
| Standard Deviation of Annual Returns | 24.12% |
| Max Drawdown | -46% |
| Market Capitalization | 784.1m USD |
| Shares Outstanding | 67 107 324 |
| Percentage of Shares Shorted | 0.01% |
